Grifols in a massive sell-off - looking for opportunities
The chart is self-explanatory!
Price to earnings getting very low, company is solid and should see a bounce sooner or later at major support levels.
Next report date
≈
May 1
Report period
Q1 2025
EPS estimate
0.15 USD
Revenue estimate
1.85 B USD
162.45 M USD
7.47 B USD
277.91 M
About GRIFOLS S.A.
Sector
Industry
CEO
Nacho Abia
Website
Headquarters
Barcelona
Founded
1940
ISIN
ES0171996087
FIGI
BBG000PS7RC0
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma Segment includes all activities related with products deriving from human plasma for therapeutic use. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.
0.8%
1.6%
2.4%
3.2%
4.0%
Q3 '23
Q4 '23
Q2 '24
Q3 '24
Q4 '24
0.00
600.00 M
1.20 B
1.80 B
2.40 B
Revenue
Net income
Net margin %
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
0.00
600.00 M
1.20 B
1.80 B
2.40 B
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
0.00
600.00 M
1.20 B
1.80 B
2.40 B
Q3 '23
Q4 '23
Q2 '24
Q3 '24
Q4 '24
0.00
3.00 B
6.00 B
9.00 B
12.00 B
Debt
Free cash flow
Cash & equivalents
No news here
Looks like there's nothing to report right now
Buy $GRFS - NRPicks 11 MarGrifols, S.A. engages in the acquisition, manufacture, preparation and sale of therapeutic products, principally plasma derivatives. The company operates through the Bioscience, Hospital, Diagnostics, Bio Supplies and Others segments.
Revenue TTM 5.6B
Net Income TTM 208M
EBITDA TTM 894M
EBITDA mar
Are we at the bottom yet?Grifols stock has been heavely punished during 2021.
First the pandemic difficulted the plasma collection. We must take into account the stimulus checks and the unemployment benefits from the US goverment wich might have disuaded people from going to the plasma collection centers to get some extra
GRIFOLS: Throw-back becoming a reality?After surpassing Fib 0.5, it looks like the stock is heading towards 0.382 level (21.81). Right now the company is immersed in a share repurchase program since 12/03/2021 and it has already acquired 19.23% of its €125 million valued shares objective. Maybe the company's financial advisers are playin
GRIFOLS: Results day coming on Feb 26. Then to the moon?68.2% of GRIFOLS revenues come from the US and Canada. Covid19 cases there seem to be decreasing. The company is delaying more and more its deadline of results for the phase III of the inmunoglobulina antiCovid-19, now until spring 2021.
If GRLS results are positive or better than expected (speciall
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
GRFS5271380
Grifols Escrow Issuer SA 4.75% 15-OCT-2028Yield to maturity
8.54%
Maturity date
Oct 15, 2028
XS239300189
GRIFOLS S.A. 21/28 REGSYield to maturity
6.86%
Maturity date
Oct 15, 2028
XS207764639
GRIFOLS 19/27 REGSYield to maturity
4.75%
Maturity date
Nov 15, 2027
See all GIFLF bonds
Frequently Asked Questions
The current price of GIFLF is 8.50 USD — it has decreased by −10.81% in the past 24 hours. Watch Grifols Sa stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Grifols Sa stocks are traded under the ticker GIFLF.
GIFLF stock has fallen by −10.90% compared to the previous week, the month change is a −24.78% fall, over the last year Grifols Sa has showed a −6.80% decrease.
We've gathered analysts' opinions on Grifols Sa future price: according to them, GIFLF price has a max estimate of 27.38 USD and a min estimate of 9.86 USD. Watch GIFLF chart and read a more detailed Grifols Sa stock forecast: see what analysts think of Grifols Sa and suggest that you do with its stocks.
GIFLF reached its all-time high on Jun 20, 2014 with the price of 57.50 USD, and its all-time low was 7.46 USD and was reached on Mar 6, 2024. View more price dynamics on GIFLF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GIFLF stock is 12.12% volatile and has beta coefficient of 1.00. Track Grifols Sa stock price on the chart and check out the list of the most volatile stocks — is Grifols Sa there?
Today Grifols Sa has the market capitalization of 5.96 B, it has decreased by −3.75% over the last week.
Yes, you can track Grifols Sa financials in yearly and quarterly reports right on TradingView.
Grifols Sa is going to release the next earnings report on May 1, 2025. Keep track of upcoming events with our Earnings Calendar.
GIFLF earnings for the last quarter are 0.24 USD per share, whereas the estimation was 0.23 USD resulting in a 3.62% surprise. The estimated earnings for the next quarter are 0.15 USD per share. See more details about Grifols Sa earnings.
Grifols Sa revenue for the last quarter amounts to 2.05 B USD, despite the estimated figure of 2.01 B USD. In the next quarter, revenue is expected to reach 1.85 B USD.
GIFLF net income for the last quarter is 71.40 M USD, while the quarter before that showed 57.55 M USD of net income which accounts for 24.05% change. Track more Grifols Sa financial stats to get the full picture.
Grifols Sa dividend yield was 0.00% in 2024, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 13, 2025, the company has 23.83 K employees. See our rating of the largest employees — is Grifols Sa on this list?
Like other stocks, GIFLF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Grifols Sa stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Grifols Sa technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Grifols Sa stock shows the strong sell signal. See more of Grifols Sa technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.